Literature DB >> 22276657

Effect of the HIV nucleoside reverse transcriptase inhibitor zidovudine on the growth and differentiation of primary gingival epithelium.

D Mitchell1, M Israr, S Alam, J Kishel, D Dinello, C Meyers.   

Abstract

OBJECTIVES: Oral complications associated with HIV infection and with the antiretroviral drugs used to treat it are of increasing concern in HIV-infected patients. Protease inhibitors have been shown to change the proliferation and differentiation state of oral tissues but the effect of nucleoside reverse transcriptase inhibitors is currently unknown. This study examined the effect of zidovudine on the growth and differentiation of the gingival epithelium.
METHODS: Gingival keratinocyte organotypic (raft) cultures were established. The raft cultures were treated with a range of zidovudine concentrations. Haematoxylin and eosin staining was performed to examine the effect of zidovudine on gingival epithelium growth and stratification. Raft cultures were immunohistochemically analysed to determine the effect of this drug on the expression of key differentiation and proliferation markers, including cytokeratins and proliferating cell nuclear antigen (PCNA).
RESULTS: Zidovudine dramatically changed the proliferation and differentiation state of gingival tissues both when it was present throughout the growth period of the tissue and when it was added to established tissue at day 8. Zidovudine treatment increased the expression of cytokeratin 10, PCNA and cyclin A. Conversely, cytokeratin 5, involucrin and cytokeratin 6 expression was decreased. The tissue exhibited characteristics of increased proliferation in the suprabasal layers as well as an increased fragility and an inability to heal itself.
CONCLUSIONS: Zidovudine treatment, even when applied at low concentrations for short periods of time, deregulated the cell cycle/proliferation and differentiation pathways, resulting in abnormal epithelial repair and proliferation. Our system could potentially be developed as a model for studying the effects of HIV and highly active antiretroviral therapy in vitro.
© 2012 British HIV Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22276657      PMCID: PMC3319519          DOI: 10.1111/j.1468-1293.2011.00973.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  47 in total

Review 1.  Epithelial structural proteins of the skin and oral cavity: function in health and disease.

Authors:  R B Presland; B A Dale
Journal:  Crit Rev Oral Biol Med       Date:  2000

2.  Gene expression of differentiation-specific keratins (K4, K13, K1 and K10) in oral non-dysplastic keratoses and lichen planus.

Authors:  B K Bloor; S V Seddon; P R Morgan
Journal:  J Oral Pathol Med       Date:  2000-09       Impact factor: 4.253

3.  Effect of highly active antiretroviral therapy on frequency of oral warts.

Authors:  D Greenspan; A J Canchola; L A MacPhail; B Cheikh; J S Greenspan
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

4.  Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy.

Authors:  Tim R Cressey; Gonzague Jourdain; Boonsong Rawangban; Supang Varadisai; Rucha Kongpanichkul; Prapan Sabsanong; Prapap Yuthavisuthi; Somnuk Chirayus; Nicole Ngo-Giang-Huong; Nipunporn Voramongkol; Somsak Pattarakulwanich; Marc Lallemant
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

5.  A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.

Authors:  A C Crémieux; C Katlama; C Gillotin; D Demarles; G J Yuen; F Raffi
Journal:  Pharmacotherapy       Date:  2001-04       Impact factor: 4.705

6.  Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium.

Authors:  Mohd Israr; Danielle Mitchell; Samina Alam; Donald Dinello; Joseph J Kishel; Craig Meyers
Journal:  Antivir Ther       Date:  2010

7.  Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma.

Authors:  S E Lim; W C Copeland
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

8.  Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

Authors:  J P Fagot; M Mockenhaupt; J N Bouwes-Bavinck; L Naldi; C Viboud; J C Roujeau
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

Review 9.  Orofacial effects of antiretroviral therapies.

Authors:  C Scully; P Diz Dios
Journal:  Oral Dis       Date:  2001-07       Impact factor: 3.511

10.  Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy.

Authors:  L L Patton; R McKaig; R Strauss; D Rogers; J J Eron
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-03
View more
  4 in total

1.  Comparisons of VLP-Based ELISA, Neutralization Assays with Native HPV, and Neutralization Assays with PsV in Detecting HPV Antibody Responses in HIV-Infected Women.

Authors:  Ping Du; Sarah Brendle; Janice Milici; Fabian Camacho; John Zurlo; Neil Christensen; Craig Meyers
Journal:  J AIDS Clin Res       Date:  2015-03

2.  HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.

Authors:  D Mitchell; M Israr; S Alam; D Dinello; J Kishel; R Jia; C Meyers
Journal:  HIV Med       Date:  2013-10-31       Impact factor: 3.180

Review 3.  Three-dimensional cell culture models for investigating human viruses.

Authors:  Bing He; Guomin Chen; Yi Zeng
Journal:  Virol Sin       Date:  2016-10-27       Impact factor: 4.327

Review 4.  Oral lichen planus: a microbiologist point of view.

Authors:  Tomás G Villa; Ángeles Sánchez-Pérez; Carmen Sieiro
Journal:  Int Microbiol       Date:  2021-03-10       Impact factor: 2.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.